Midcap Stocks Research: Get 3 Years of Access for the Price of 1
Here is the latest financial fact sheet of SUDARSHAN PHARMA. For more details, see the SUDARSHAN PHARMA quarterly results and SUDARSHAN PHARMA share price.
1 Day | % | -1.7 |
No. of shares | m | 24.07 |
1 Week | % | -4.6 |
1 Month | % | -10.9 |
1 Year | % | -0.4 |
52 week H/L | Rs | 91.9/62.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SUDARSHAN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | 73 | |
Low | Rs | NA | NA | NA | NA | 52 | |
Sales per share (Unadj.) | Rs | 145.7 | 155.0 | 202.5 | 366.3 | 191.7 | |
Earnings per share (Unadj.) | Rs | 2.5 | 1.3 | 2.8 | 5.4 | 2.9 | |
Diluted earnings per share | Rs | 1.0 | 0.5 | 1.1 | 2.2 | 2.9 | |
Cash flow per share (Unadj.) | Rs | 2.6 | 1.7 | 3.6 | 6.3 | 3.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.30 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0.5 | |
Book value per share (Unadj.) | Rs | 19.6 | 20.8 | 23.6 | 30.5 | 41.9 | |
Adj. book value per share | Rs | 7.8 | 8.2 | 9.4 | 12.4 | 42.0 | |
Shares outstanding (eoy) | m | 9.55 | 9.55 | 9.55 | 9.75 | 24.07 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0.3 | |
Avg P/E ratio | x | 0 | 0 | 0 | 0 | 21.4 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | 18.9 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | 1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 10.3 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | 1,505 | |
Total wages/salary | Rs m | 25 | 15 | 14 | 17 | 21 |
SUDARSHAN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,391 | 1,480 | 1,934 | 3,571 | 4,613 | |
Other income | Rs m | 9 | 0 | 4 | 5 | 11 | |
Total revenues | Rs m | 1,400 | 1,480 | 1,937 | 3,576 | 4,624 | |
Gross profit | Rs m | 43 | 48 | 72 | 109 | 147 | |
Depreciation | Rs m | 1 | 3 | 7 | 9 | 9 | |
Interest | Rs m | 18 | 27 | 32 | 34 | 54 | |
Profit before tax | Rs m | 33 | 17 | 36 | 71 | 95 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 9 | 4 | 9 | 19 | 25 | |
Profit after tax | Rs m | 23 | 13 | 27 | 52 | 70 | |
Gross profit margin | % | 3.1 | 3.2 | 3.7 | 3.1 | 3.2 | |
Effective tax rate | % | 28.1 | 25.7 | 25.3 | 26.4 | 25.9 | |
Net profit margin | % | 1.7 | 0.9 | 1.4 | 1.5 | 1.5 |
SUDARSHAN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 407 | 469 | 876 | 1,296 | 1,986 | |
Current liabilities | Rs m | 269 | 313 | 712 | 1,026 | 1,185 | |
Net working cap to sales | % | 9.9 | 10.5 | 8.5 | 7.5 | 17.4 | |
Current ratio | x | 1.5 | 1.5 | 1.2 | 1.3 | 1.7 | |
Inventory Days | Days | 15 | 14 | 10 | 1 | 11 | |
Debtors Days | Days | 680 | 66,288,953 | 1,140 | 751 | 645 | |
Net fixed assets | Rs m | 94 | 114 | 116 | 79 | 339 | |
Share capital | Rs m | 95 | 95 | 95 | 97 | 241 | |
"Free" reserves | Rs m | 92 | 103 | 130 | 200 | 769 | |
Net worth | Rs m | 187 | 198 | 225 | 298 | 1,010 | |
Long term debt | Rs m | 45 | 70 | 53 | 49 | 128 | |
Total assets | Rs m | 501 | 582 | 993 | 1,375 | 2,325 | |
Interest coverage | x | 2.8 | 1.6 | 2.1 | 3.1 | 2.8 | |
Debt to equity ratio | x | 0.2 | 0.4 | 0.2 | 0.2 | 0.1 | |
Sales to assets ratio | x | 2.8 | 2.5 | 1.9 | 2.6 | 2.0 | |
Return on assets | % | 8.3 | 6.9 | 5.9 | 6.3 | 5.4 | |
Return on equity | % | 12.5 | 6.4 | 11.9 | 17.6 | 7.0 | |
Return on capital | % | 21.9 | 16.5 | 24.4 | 30.3 | 13.1 | |
Exports to sales | % | 0 | 0 | 0 | 1.6 | 0.7 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 58 | 31 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 58 | 31 | |
Fx outflow | Rs m | 0 | 0 | 0 | 202 | 44 | |
Net fx | Rs m | 0 | 0 | 0 | -145 | -13 |
SUDARSHAN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -10 | 5 | 28 | -38 | -288 | |
From Investments | Rs m | -35 | -25 | -13 | -15 | -257 | |
From Financial Activity | Rs m | 80 | -3 | -15 | 43 | 659 | |
Net Cashflow | Rs m | 34 | -23 | -0 | -10 | 115 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Hemal Mehta | COMP SEC: Ishita Ashok Samani | YEAR OF INC: 2008 | BSE CODE: 543828 | FV (Rs): 10 | DIV YIELD (%): 0.4 |
More Pharmaceuticals Company Fact Sheets: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
Compare SUDARSHAN PHARMA With: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
After opening the day marginally higher, Indian share markets continued the momentum as the session progressed and ended the day higher.